Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study von Collea, R.P., Kruter, F.W., Cantrell, J.E., George, T.K., Kruger, S., Favret, A.M., Lindquist, D.L., Melnyk, A.M., Pluenneke, R.E., Shao, S.H., Crockett, M.W., Asmar, L., O’Shaughnessy, J.

Volltext

Results of a phase II study of single-agent sunitinib in elderly non-small cell lung cancer patients von Reynolds, C., Spira, A. I., Gluck, W. L., Pluenneke, R. E., Boehm, K. A., Zhan, F., Asmar, L.

Volltext

Abstract S4-2: First Efficacy Results of a Randomized, Open-Label, Phase III Study of Adjuvant Doxorubicin Plus Cyclophosphamide, Followed by Docetaxel with or without Capecitabine... von O'Shaughnessy, J, Paul, D, Stokoe, C, Pippen Jr, J, Blum, JL, Krekow, L, Holmes, FA, Vukelja, S, Lindquist, D, Sedlacek, S, Rivera, R, Brooks, R, McIntyre, K, Pluenneke, R, Schwartz, J, Jones, S, Brownstein, C, Gilberg, F.

Volltext

Preliminary Toxicity Results of a Phase II Randomized Trial of Weekly or Every 3-Week Ixabepilone in Metastatic Breast Cancer (MBC) von Smith II, J., Smith II, J., Vukelja, S., Vukelja, S., Rabe, A., Rabe, A., Pluenneke, R., Pluenneke, R., Wentworth-Hartung, N., Wentworth-Hartung, N., Benaderet, L., Benaderet, L., Koutrelakos, N., Koutrelakos, N., Robbins, G., Robbins, G., Shao, S., Shao, S., Whittaker, T., Greco, A., Wang, Y., Boehm, K., Asmar, L., Opatt, D., O'Shaughnessy, J., O'Shaughnessy, J.

Volltext

Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study von Urba, Susan G, Chansky, Kari, VanVeldhuizen, Peter J, Pluenneke, Robert E, Benedetti, Jacqueline K, Macdonald, John S, Abbruzzese, James L

Volltext

Phase II study of pegylated liposomal doxorubicin (PLD) and carboplatin (Cb) can be administered with trastuzumab (H) in patients with metastatic breast cancer von Collea, RP, Kruter, FW, Cantrell, JE, George, TK, Kruger, S, Favret, AM, Lindquist, DL, Melnyk Jr, AM, Pluenneke, RE, Shao, SH, Crockett, MW, Asmar, L, O'Shaughnessy, JA

Volltext

influence of low substrate sodium levels upon the free amino acid content of cotton leaves von Pluenneke, R.H, Joham, H.E

Volltext

Variable rate system works in Texas von Word, J.D. (Austin Environmental and Conservation Service), Higginbotham, K, Pluenneke, D.R

Volltext

Dimethyl Sulfoxide (DMSO): Influence on Bean Pod Mottle Disease and Interaction with Disulfoton and Phorate1 von Pitre, H. N., Pluenneke, R. H., Bhirud, K. M., Palmer, S. E.

Volltext

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer von Yoder, Rachel, Kimler, Bruce F., Staley, Joshua M., Schwensen, Kelsey, Wang, Yen Y., Finke, Karissa, O’Dea, Anne, Nye, Lauren, Elia, Manana, Crane, Gregory, McKittrick, Richard, Pluenneke, Robert, Madhusudhana, Sheshadri, Beck, Larry, Shrestha, Anuj, Corum, Larry, Marsico, Mark, Stecklein, Shane R., Godwin, Andrew K., Khan, Qamar J., Sharma, Priyanka

Volltext

Bringing experimental therapeutics clinical trials network (ETCTN) to underrepresented population von Baranda, Joaquina Celebre, Doolittle, Gary C., Parikh, Rahul Atul, Kasi, Anup, Wulff-Burchfield, Elizabeth Marie, Powers, Benjamin, Pluenneke, Robert E., Hoffmann, Marc Steven, Yacoub, Abdulraheem, Saeed, Anwaar, Corum, Larry R., Lin, Tara L., Sun, Weijing, Mooney, Margaret M., Moscow, Jeffrey, Doroshow, James H., Waters, Brittany, Ivy, S. Percy, Gore, Steven, Jensen, Roy A.

Volltext

Dimethyl sulfoxide (DMSO): influence on bean pod mottle disease and interaction with disulfoton and phorate von Pitre, H.N, Pluenneke, R.H, Bhirud, K.M, Palmer, S.E

Volltext

Phase II Trial of Docetaxel/Capecitabine in Hormone-Refractory Prostate Cancer von Kolodziej, Michael, Neubauer, Marcus A., Rousey, Steven R., Pluenneke, Robert E., Perrine, George, Mull, Stephanie, Boehm, Kristi A., Ilegbodu, Des, Asmar, Lina

Volltext